Market Tracker

04/17 6:05pm ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

1.19
Data as of Apr 17
 +0.03 / +2.59%
Today’s Change
0.65
Today|||52-Week Range
4.00
+28.65%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close1.16
Today’s open1.17
Day’s range1.14 - 1.20
Volume505,740
Average volume (3 months)2,069,028
Market cap$72.0M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-56.25%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CDXSCodexis Inc-0.02-1.13%
AEZSAEterna Zentaris Inc+0.03+2.68%
ENMDEntreMed Inc-0.05-2.60%
BCLIBrainstorm Cell Ther...+0.00+1.96%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateMay 8, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts